Trial · NCT03226678
Results by group108
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 108
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 270 mg | All TEAEs | 5 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 360 mg | All TEAEs | 5 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 270 mg | All TEAEs | 7 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 360 mg | All TEAEs | 6 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 1 wAIHA - 1080 mg | All TEAEs | 5 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 2 CAD - 1080 mg | All TEAEs | 9 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 270 mg | Treatment related TEAEs | 4 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 360 mg | Treatment related TEAEs | 4 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 270 mg | Treatment related TEAEs | 5 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 360 mg | Treatment related TEAEs | 4 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 1 wAIHA - 1080 mg | Treatment related TEAEs | 4 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 2 CAD - 1080 mg | Treatment related TEAEs | 5 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 270 mg | Serious AEs | 3 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 360 mg | Serious AEs | 2 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 270 mg | Serious AEs | 3 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 2 CAD - 360 mg | Serious AEs | 2 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 1 wAIHA - 1080 mg | Serious AEs | 2 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part B: Cohort 2 CAD - 1080 mg | Serious AEs | 6 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 270 mg | TEAEs leading to study drug discontinuation | 1 | Participants | |
| Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity | Part A: Cohort 1 wAIHA - 360 mg | TEAEs leading to study drug discontinuation | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226678/results